Sign up for free insights newsletter
Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited

4502Tokyo Stock Exchange

Need professional-grade analysis? Visit stockanalysis.com

¥5,663.00
+1.54%
End of day
Market Cap

$8.10T

P/E Ratio

N/A

Employees

N/A

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-2.60-2.145.835.131.762.66
Calmar-17.87-8.0615.8612.872.135.05
Sharpe-2.67-1.753.523.131.271.55
Omega0.170.691.601.531.241.25
Martin-33.75-18.1649.6633.586.0516.23
Ulcer2.642.221.591.914.702.87

Takeda Pharmaceutical Company Limited (4502) Price Performance

Takeda Pharmaceutical Company Limited (4502) trades on Tokyo Stock Exchange in JPY. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at JPY5663.00, up 1.54% from the previous close.

Over the past year, 4502 has traded between a low of JPY3844.38 and a high of JPY5870.00. The stock has gained 30.6% over this period. It is currently 47.3% above its 52-week low.

Takeda Pharmaceutical Company Limited has a market capitalization of $8.10T.

About Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited (4502) is a multinational pharmaceutical company headquartered in Japan. The company focuses on developing and marketing innovative pharmaceutical products in therapeutic areas such as oncology, gastroenterology, neuroscience, and rare diseases. Takeda operates globally, with a presence in over 80 countries, and is committed to improving people's health and well-being through its diverse portfolio of medicines and research and development efforts.

Company Info

Exchange
Tokyo Stock Exchange
Currency
JPY
Country
Japan

Financial Metrics

Revenue (TTM)
N/A
EBITDA
N/A
Profit Margin
N/A
EPS (TTM)
N/A
Book Value
N/A

Technical Indicators

52 Week High
¥5,877.00
52 Week Low
¥3,827.76
50 Day MA
¥5,484.34
200 Day MA
¥4,634.05
Beta
N/A

Valuation

Trailing P/E
N/A
Forward P/E
N/A
Price/Sales
N/A
Price/Book
N/A
Enterprise Value
$8.10T